Twelve reasons delays in uveal melanoma treatment might affect prognosis.
作者信息
Stålhammar Gustav
机构信息
Ocular Oncology and Pathology Services, St. Erik Eye Hospital, Stockholm, Sweden
Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
出版信息
Br J Ophthalmol. 2025 Aug 20;109(9):967-969. doi: 10.1136/bjo-2025-327294.
Abstract
摘要
相似文献
1
Twelve reasons delays in uveal melanoma treatment might affect prognosis.葡萄膜黑色素瘤治疗延迟可能影响预后的十二个原因。
Br J Ophthalmol. 2025 Aug 20;109(9):967-969. doi: 10.1136/bjo-2025-327294.
2
Characterization, treatment, and outcome of uveal melanoma in the first two years of life.1岁前两年葡萄膜黑色素瘤的特征、治疗及转归
Hematol Oncol Stem Cell Ther. 2015 Mar;8(1):1-5. doi: 10.1016/j.hemonc.2014.09.004. Epub 2014 Oct 6.
3
Obesity paradox in uveal melanoma: high body mass index is associated with low metastatic risk.葡萄膜黑色素瘤中的肥胖悖论：高身体质量指数与低转移风险相关。
Br J Ophthalmol. 2024 Mar 20;108(4):578-587. doi: 10.1136/bjo-2022-322877.
4
Analysis of Lysyl Oxidase Expression and Vascular Bed in Human Uveal Melanoma.人葡萄膜黑色素瘤中赖氨酰氧化酶表达及血管床分析
Bull Exp Biol Med. 2025 Jul 19. doi: 10.1007/s10517-025-06441-8.
5
DJ-1: a promising marker in metastatic uveal melanoma.DJ-1：转移性葡萄膜黑色素瘤中一个有前景的标志物。
J Cancer Res Clin Oncol. 2015 Feb;141(2):315-21. doi: 10.1007/s00432-014-1804-2. Epub 2014 Aug 17.
6
Monitoring soluble cMET and ctDNA in metastatic uveal melanoma patients to track early disease progression on immunotherapies.监测转移性葡萄膜黑色素瘤患者的可溶性cMET和循环肿瘤DNA，以追踪免疫治疗中疾病的早期进展。
J Exp Clin Cancer Res. 2025 Jul 19;44(1):213. doi: 10.1186/s13046-025-03451-2.
7
The long-term prognosis of patients with untreated primary uveal melanoma: A systematic review and meta-analysis.未经治疗的原发性眼葡萄膜黑素瘤患者的长期预后：系统评价和荟萃分析。
Crit Rev Oncol Hematol. 2022 Apr;172:103652. doi: 10.1016/j.critrevonc.2022.103652. Epub 2022 Mar 15.
8
Uveal melanoma.葡萄膜黑色素瘤
Semin Diagn Pathol. 2016 May;33(3):141-7. doi: 10.1053/j.semdp.2015.10.005. Epub 2016 Mar 10.
9
Choroidal nevi and melanoma doubling times and implications for delays in treatment: A systematic review and meta-analysis.脉络膜痣和黑色素瘤的倍增时间及其对治疗延迟的影响：系统评价和荟萃分析。
Surv Ophthalmol. 2025 Jan-Feb;70(1):38-46. doi: 10.1016/j.survophthal.2024.09.004. Epub 2024 Sep 28.
10
Delays in the diagnosis of uveal melanoma and effect on treatment.葡萄膜黑色素瘤的诊断延误及其对治疗的影响。
Eye (Lond). 1998;12 ( Pt 5):781-2. doi: 10.1038/eye.1998.202.
本文引用的文献
1
Higher AJCC stage at primary tumor diagnosis may predict shorter survival in metastatic uveal melanoma.原发性肿瘤诊断时较高的美国癌症联合委员会（AJCC）分期可能预示转移性葡萄膜黑色素瘤的生存期较短。
Sci Rep. 2025 Jun 4;15(1):19557. doi: 10.1038/s41598-025-03961-1.
2
Expert Opinions on Uveal Melanoma: Insights from the 58th Ophthalmic Oncology Group Meeting.葡萄膜黑色素瘤专家意见：来自第58届眼科肿瘤学组会议的见解
Ocul Oncol Pathol. 2024 Dec;10(4):197-205. doi: 10.1159/000541016. Epub 2024 Aug 27.
3
Survival Benefit of Primary Tumor Treatment in Uveal Melanoma: A Re-Analysis of the Collaborative Ocular Melanoma Study (COMS) and Natural History Study (NHS) Cohorts.葡萄膜黑色素瘤原发肿瘤治疗的生存获益：协作性眼黑色素瘤研究（COMS）和自然病史研究（NHS）队列的重新分析
Cancers (Basel). 2024 Nov 15;16(22):3839. doi: 10.3390/cancers16223839.
4
Choroidal nevi and melanoma doubling times and implications for delays in treatment: A systematic review and meta-analysis.脉络膜痣和黑色素瘤的倍增时间及其对治疗延迟的影响：系统评价和荟萃分析。
Surv Ophthalmol. 2025 Jan-Feb;70(1):38-46. doi: 10.1016/j.survophthal.2024.09.004. Epub 2024 Sep 28.
5
Re: Stålhammar G: Delays between uveal melanoma diagnosis and treatment increase the risk of metastatic death (Ophthalmology. 2024;131:1094-1104).关于：斯塔尔哈马尔 G：葡萄膜黑色素瘤诊断与治疗之间的延迟会增加转移性死亡风险（《眼科学》。2024 年；131 卷：1094 - 1104 页）。
Ophthalmology. 2024 Sep;131(9):e39. doi: 10.1016/j.ophtha.2024.05.001. Epub 2024 Jun 13.
6
Do Short Delays in Treatment Affect Uveal Melanoma Prognosis?治疗延迟会影响葡萄膜黑色素瘤的预后吗？
Ophthalmology. 2024 Sep;131(9):1105-1106. doi: 10.1016/j.ophtha.2024.05.018. Epub 2024 Jun 12.
7
Reply.回复。
Ophthalmology. 2024 Sep;131(9):e40-e41. doi: 10.1016/j.ophtha.2024.05.002. Epub 2024 Jun 13.
8
Deferral of Treatment for Small Choroidal Melanoma and the Risk of Metastasis: An Investigation Using the Liverpool Uveal Melanoma Prognosticator Online (LUMPO).小脉络膜黑色素瘤治疗延迟与转移风险：一项使用利物浦葡萄膜黑色素瘤预后在线工具（LUMPO）的调查
Cancers (Basel). 2024 Apr 22;16(8):1607. doi: 10.3390/cancers16081607.
9
Improved Staging of Ciliary Body and Choroidal Melanomas Based on Estimation of Tumor Volume and Competing Risk Analyses.基于肿瘤体积估计和竞争风险分析的睫状体和脉络膜黑色素瘤分期的改进
Ophthalmology. 2024 Apr;131(4):478-491. doi: 10.1016/j.ophtha.2023.10.026. Epub 2023 Oct 29.
10
Delays between Uveal Melanoma Diagnosis and Treatment Increase the Risk of Metastatic Death.葡萄膜黑色素瘤的诊断和治疗延误增加转移死亡的风险。
Ophthalmology. 2024 Sep;131(9):1094-1104. doi: 10.1016/j.ophtha.2023.11.021. Epub 2023 Nov 21.
Zotero 插件